Abstract
Hypoxia is a major driver of tumor aggressiveness and therapy resistance in GBM. In this issue of Immunity, Sattiraju et al. functionally link hypoxia with diminished anti-cancer immunity caused by sequestration of immunosuppressive TAMs and CTLs in pseudopalisades in GBM.
Cite
CITATION STYLE
APA
Möckl, A., & Sevenich, L. (2023, August 8). Take my breath away: TAM-ing anti-cancer immunity in hypoxic niches. Immunity. Cell Press. https://doi.org/10.1016/j.immuni.2023.07.010
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free